UK markets close in 2 minutes

Vifor Pharma AG (GNHAY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
34.800.00 (0.00%)
As of 11:33AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 11.90B
Enterprise value 11.48B
Trailing P/E 75.62
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.06
Price/book (mrq)3.16
Enterprise value/revenue 6.29
Enterprise value/EBITDA 17.93

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 329.85%
S&P500 52-week change 3-16.62%
52-week high 337.70
52-week low 325.50
50-day moving average 335.97
200-day moving average 335.62

Share statistics

Avg vol (3-month) 314
Avg vol (10-day) 3N/A
Shares outstanding 5324.46M
Implied shares outstanding 6N/A
Float 84.8M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.41
Forward annual dividend yield 41.18%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 35.75%
5-year average dividend yield 4N/A
Payout ratio 488.23%
Dividend date 319 May 2022
Ex-dividend date 411 May 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 7.97%
Operating margin (ttm)20.94%

Management effectiveness

Return on assets (ttm)4.60%
Return on equity (ttm)6.65%

Income statement

Revenue (ttm)1.81B
Revenue per share (ttm)5.59
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.14B
Net income avi to common (ttm)146.6M
Diluted EPS (ttm)0.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)993.6M
Total cash per share (mrq)3.06
Total debt (mrq)587.5M
Total debt/equity (mrq)14.80
Current ratio (mrq)1.91
Book value per share (mrq)10.76

Cash flow statement

Operating cash flow (ttm)527.4M
Levered free cash flow (ttm)303.36M